Clinical Trial Update: Evaluate Efficacy and Safety of POS to Improve Distance-corrected Near Visual in Participants With Presbyopia [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of POS to improve distance-corrected near vision in presbyopia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Presbyopia

Drugs mentioned

• POS

Snippet

Sponsor: Ocuphire Pharma, Inc. | Conditions: Presbyopia | Phase 3 | Status: COMPLETED